6/5/2013

Navidea Biopharmaceuticals said findings from research addressing its Lymphoseek and NAV4694 radiopharmaceuticals will be shared at the SNMMI Annual Meeting. Ten presentations will focus on Lymphoseek compared with nonreceptor-targeted colloidal materials, while four will focus on beta-amyloid PET imaging agent NAV4694.

Related Summaries